Immunotherapy takes two steps forward (new FDA approvals)....and two steps backwards.  These updates in #oncopharm are discussed before ending (11:45) with discussions of venetoclax's expanded approval in CLL, the bevacizumab approval almost 7 years in the making, and late-breaking information on preventing cisplatin ototoxicity.

Immunotherapy takes two steps forward (new FDA approvals)....and two steps backwards.  These updates in #oncopharm are discussed before ending

Encorafenib & Binimetinib

OncoPharm is a podcast dedicated to all things oncology pharmacy.  Most episodes cover updates and recent publications concerning the use of medications in caring for patients we cancer.  Periodically, episodes drop devoted to Landmark Clinical Trials in oncology and Fundamentals of Oncology Pharmacy.